Vascular mimicry: A potential therapeutic target in breast cancer

被引:13
|
作者
Chavoshi, Hadi [1 ]
Poormolaie, Neda [2 ]
Vahedian, Vahid [3 ]
Kazemzadeh, Hamid [4 ]
Mir, Amirabbas [5 ]
Nejabati, Hamid Reza [4 ]
Behroozi, Javad [6 ]
Isazadeh, Alireza [7 ]
Hajezimian, Saba [7 ]
Nouri, Mohammad [4 ]
Maroufi, Nazila Fathi [4 ]
机构
[1] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran
[2] Islamic Azad Univ, Fac Biol Sci, Dept Biochem, North Tehran Branch, Tehran, Iran
[3] Sao Paulo State Univ UNESP, Dept Pathol, Canc Biol Res Grp, Inst Biotechnol FMB IBTEC,Fac Med,Mol Oncol, Sao Paulo, Brazil
[4] Tabriz Univ Med Sci, Fac Med, Dept Biochem & Clin Labs, Tabriz, Iran
[5] Univ Kashan, Inst Nano Sci & Nano Technol, POB 87317-51167, Kashan, Iran
[6] Tarbiat Modares Univ, Fac Med Sci, Dept Med Genet, Tehran, Iran
[7] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
关键词
Angiogenesis; Breast cancer; VM; Therapeutic Target; Metastasis; SUPPRESSES VASCULOGENIC MIMICRY; POOR-PROGNOSIS; STEM-CELLS; NEGATIVE REGULATOR; EXPRESSION; METASTASIS; INHIBITION; GROWTH; SURVIVAL; LRIG1;
D O I
10.1016/j.prp.2022.153922
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Treating breast cancer, especially in the invasive state, is one of the challenges in treating cancer. Invasion and metastasis are factors in the failure of breast cancer treatments. One of the causes of this failure is the formation of new blood vessels to nourish the tumor cells. Although many drugs target the formation of blood vessels, the therapeutic results, especially in breast cancer, have not been very successful and even recurrence of the disease has been observed. Therefore, it can be concluded that other mechanisms are involved in feeding and delivering oxygen to tumor cells, the most important of which is the vascular mimicry (VM). The ability of cancer cells to organize themselves into vascular-like structures for the obtain of nutrients and oxygen independently of normal blood vessels or angiogenesis named Vasculogenic mimicry. In this review article, we tried to review the formation VM and the therapeutic potential of targeting VM formation in the treatment of breast cancer.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Vascular Pathology as a Potential Therapeutic Target in SCI
    Benton, Richard L.
    Hagg, Theo
    TRANSLATIONAL STROKE RESEARCH, 2011, 2 (04) : 556 - 574
  • [42] Vascular mimicry in metastatic breast cancer patients: Molecular insight to vascular mimicry using in vitro and in vivo models
    Dey, N.
    Carlson, J. H.
    Lin, X.
    Sun, Y.
    Theel, S.
    Krie, A.
    Sulaiman, R. A.
    Williams, C.
    De, P. K.
    Leyland-Jones, B. R.
    CANCER RESEARCH, 2016, 76
  • [43] Epigenetics as a Therapeutic Target in Breast Cancer
    Connolly, Roisin
    Stearns, Vered
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2012, 17 (3-4) : 191 - 204
  • [44] Angiogenesis as a therapeutic target in breast cancer
    Koutras, Angelos K.
    Starakis, Ioannis
    Lymperatou, Dionysia
    Kalofonos, Haralabos P.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (12) : 1230 - 1238
  • [45] Epigenetics as a Therapeutic Target in Breast Cancer
    Roisin Connolly
    Vered Stearns
    Journal of Mammary Gland Biology and Neoplasia, 2012, 17 : 191 - 204
  • [46] Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
    Michael J. Duffy
    Naoise C. Synnott
    John Crown
    Breast Cancer Research and Treatment, 2018, 170 : 213 - 219
  • [47] Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
    Duffy, Michael J.
    Synnott, Naoise C.
    Crown, John
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (02) : 213 - 219
  • [48] Identification of PADI2 as a potential breast cancer biomarker and therapeutic target
    John L McElwee
    Sunish Mohanan
    Obi L Griffith
    Heike C Breuer
    Lynne J Anguish
    Brian D Cherrington
    Ashley M Palmer
    Louise R Howe
    Venkataraman Subramanian
    Corey P Causey
    Paul R Thompson
    Joe W Gray
    Scott A Coonrod
    BMC Cancer, 12
  • [49] Identification of PADI2 as a potential breast cancer biomarker and therapeutic target
    McElwee, John L.
    Mohanan, Sunish
    Griffith, Obi L.
    Breuer, Heike C.
    Anguish, Lynne J.
    Cherrington, Brian D.
    Palmer, Ashley M.
    Howe, Louise R.
    Subramanian, Venkataraman
    Causey, Corey P.
    Thompson, Paul R.
    Gray, Joe W.
    Coonrod, Scott A.
    BMC CANCER, 2012, 12
  • [50] Delay Discounting as a Potential Therapeutic Target for Weight Loss in Breast Cancer Survivors
    Sukumar, Jasmine S.
    Vaughn, Jennifer E.
    Tegge, Allison
    Sardesai, Sagar
    Lustberg, Maryam
    Stein, Jeffrey
    CANCERS, 2022, 14 (05)